Skip to content

Mark McNamara, M.D.

NPI 1275640294ActiveIndividual· Internal Medicine, Hematology & Oncology· Pasadena, CA

Internal Medicine, Hematology & Oncology (M.D.) in Pasadena, California, licensed in CA, with an NPI issued in August 2006. Part D covered 15 prescriptions written in 2024, 80% of them generic. Merck Sharp & Dohme LLC reported $25.70 in payments in 2025, mostly education.

Overview

NPI1275640294
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedAug 24, 2006
Last updated in NPPESNov 27, 2023
Certified by providerSep 29, 2020

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (CA)

Part D prescriptions in 2024

Prescriptions (claims)15 · 32 30-day fills
Total drug cost$5,381
Generic share80% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$25.70 · 1 payment from 1 company
  • 2024$18.09 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Merck Sharp & Dohme LLC$25.701

What the 2025 payments were for

  • Education$25.70 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology & Oncology providers in Pasadena

All Internal Medicine, Hematology & Oncology providers in California →